Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company discovering and developing precision medicines for oncology and inflammatory diseases utilizing its proprietary Generative artificial intelligence (AI)-driven, Phosphoproteomics Acrivon Predictive Precision Proteomics (AP3) platform. Its lead program, ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 in a potentially registrational Phase II trial for endometrial cancer (EC). It is advancing ACR-7280, its next AP3-enabled innovation program, a first-in-class, oral, highly selective CDK11 inhibitor development candidate, in IND-enabling studies. Its immunology and inflammation pipeline, ACR-525, a Phase II-ready, oral, highly selective JAK1 inhibitor. Additionally, the Company has a preclinical PKCθ inhibitor preclinical program, an attractive target for T-cell-driven autoimmune and inflammatory diseases, with the potential to be developed in combination with ACR-525 and other I&I therapies.
Find out what a historical investment in ACRIVON THERAPEUTICS, INC. would be worth today using our ACRV stock calculator.
Buying ACRV shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ACRIVON THERAPEUTICS, INC. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in ACRV
What is the ticker symbol of ACRIVON THERAPEUTICS, INC.?
The ticker symbol for ACRIVON THERAPEUTICS, INC. is ACRV.
How much is one share of ACRV?
One share of ACRV is valued at $1.40 as of 20 November 2026.
What is the market capitalisation of ACRIVON THERAPEUTICS, INC. ACRV?
As of 20 November 2026 ACRIVON THERAPEUTICS, INC. has a market cap of $66.94M.
What is the 52-week high for ACRIVON THERAPEUTICS, INC. stock?
The ACRIVON THERAPEUTICS, INC. 52-week high stock price is $3.56.
What is the 52-week low for ACRIVON THERAPEUTICS, INC. stock?
The ACRIVON THERAPEUTICS, INC. 52-week low stock price is $1.27.
Can I buy ACRV shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ACRV shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ACRV on Stake
Buy ACRV from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of ACRV from only US$10 with fractional shares